Merck Ends Development of Two Potential COVID-19 Vaccines
The drugmaker will stop developing two potential COVID-19 vaccines after seeing poor results in early-stage studies.
The drugmaker will stop developing two potential COVID-19 vaccines after seeing poor results in early-stage studies.
Study finds slightly higher risk in children at 10 years, but experts say this shouldn’t change current supplementation recommendations.
A study in a primarily Hispanic population points to the need for improved communication between patients and providers.
La mise à jour des vaccins devrait permettre de maintenir la protection contre le COVID-19 alors que le virus continue d’évoluer, selon l’agence européenne du…
CGM SWEET TALK WITH THE SUGAR QUEENS is a monthly series broadcast live from Medscape’s social media channels. Monday, April 22, 2024: Impact of CGM…
A useful summary on NICE’s guideline on the assessment and management of co-morbidities, and how to assess frailty
Join us for a symposium on ulcerative colitis (UC) designed to encourage the exchange of ideas between leaders in the field and attendees. This event…
Following a medically supervised energy-restricted diet 2 days a week could improve glycemic control in patients with overweight or mild obesity and type 2 diabetes.
Psychedelic-assisted therapy is poised to move from the research setting to clinical practice, and a group of experts offer seven essential elements of informed consent…
An up-to-date NICE guideline summary on the assessment and management of lower urinary tract symptoms (LUTS) in men
Measles resurgence threatens global health, with rising cases and travel-related risks. Experts discuss the outbreak’s impact on healthcare.